We thank Muhammad Abdul Rehman Jauhar for the help with the literature search and editing of the article.
Author contributions
SJ: Conceptualization, Writing—original draft, Writing—review & editing. AU: Writing—review & editing. ASS: Conceptualization, Writing—original draft, Writing—review & editing. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that there are no conflicts of interest.
Ethical approval
The study was conducted in accordance with institutional guidelines and the principles of the Declaration of Helsinki. A formal ethical approval was not required for this retrospective case report.
Consent to participate
Informed consent to participate in the study was obtained from the patient.
Consent to publication
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Availability of data and materials
The data supporting the findings of this study are available from the corresponding author upon reasonable request.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Butler J, Talha KM, Aktas MK, Zareba W, Goldenberg I. Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy.Circ Heart Fail. 2022;15:e009634. [DOI] [PubMed]
Ammannaya GKK. Implantable cardioverter defibrillators - the past, present and future.Arch Med Sci Atheroscler Dis. 2020;5:e163–70. [DOI] [PubMed] [PMC]
Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.Heart Rhythm. 2008;5:e1–62. [DOI] [PubMed]
Dodson JA, Reynolds MR, Bao H, Al-Khatib SM, Peterson ED, Kremers MS, et al. Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry).J Am Coll Cardiol. 2014;63:788–96. [DOI] [PubMed] [PMC]
Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation?Open Heart. 2015;2:e000198. [DOI] [PubMed] [PMC]
Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, et al.; Heart Rhythm Society; American Heart Association. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).Heart Rhythm. 2009;6:1085–104. [DOI] [PubMed]
Hauser RG, Katsiyiannis WT, Gornick CC, Almquist AK, Kallinen LM. Deaths and cardiovascular injuries due to device-assisted implantable cardioverter-defibrillator and pacemaker lead extraction.Europace. 2010;12:395–401. [DOI] [PubMed] [PMC]
Latifi AN, Ibe U, Jiwa N. Acute stroke secondary to AICD lead malposition in the left ventricle.J Cardiol Curr Res. 2019;12:69–72. [DOI]
Ferreira JADS, Domingues CM, da Costa SIMD, Silva MFF, Gonçalves LMM. A Rare Complication of Implantable Cardiac Defibrillator Placement.J Cardiovasc Echogr. 2020;30:167–70. [DOI] [PubMed] [PMC]
McManus DD, Mattei M, Rose K, Rashkin J, Rosenthal LS. Inadvertent lead placement in the left ventricle: a case report and brief review.Indian Pacing Electrophysiol J. 2009;9:224–8. [PubMed] [PMC]
Carretta D, Castellano M, Gianfrancesco D, De Michele L, Cozzolino M, Pedote P, et al. Inadvertent left ventricular placement of ICD lead through the left subclavian artery right positioned in a patient with situs viscerum inversus and Kartagener syndrome.J Cardiol Cases. 2021;25:26–9. [DOI] [PubMed] [PMC]
Borgquist R, Farouq M, Markstad H, Brandt J, Mörtsell D, Jensen S, et al. Diagnosis and treatment of the rare procedural complication of malpositioned pacing leads in the left heart: a single center experience.Scand Cardiovasc J. 2022;56:302–9. [DOI] [PubMed]
Osman A, Ahmad A. Saved by anticoagulants: Incidental discovery of a misplaced defibrillator lead 6 years after implantation. Inadvertent lead placement inside the left ventricular cavity.Clin Case Rep. 2021;9:2445–8. [DOI] [PubMed] [PMC]
Javanmardi E, Ehlert F, Yarmohammadi H. A Curious Presentation of Chronic Chest Pain.Circulation. 2023;148:610–2. [DOI] [PubMed]
Helal A, Antoun I, El-Din M, Farooq M. When Patent Foramen Ovale (PFO) Can Cause Trouble-A Misplacement of Pacemaker Lead Into the Left Ventricle.Case Rep Cardiol. 2026;2026:6816373. [DOI] [PubMed] [PMC]
Liebold A, Aebert H, Muscholl M, Birnbaum DE. Cerebral embolism due to left ventricular pacemaker lead: removal with cardiopulmonary bypass.Pacing Clin Electrophysiol. 1994;17:2353–5. [DOI] [PubMed]
Indja B, Woldendorp K, Vallely MP, Grieve SM. Silent Brain Infarcts Following Cardiac Procedures: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2019;8:e010920. [DOI] [PubMed] [PMC]
Contractor T, Co ML, Cooper JM, Mandapati R, Abudayyeh I. Management of inadvertent lead placement in the left ventricle via a patent foramen ovale: A multidisciplinary approach.HeartRhythm Case Rep. 2019;6:89–93. [DOI] [PubMed] [PMC]
Rodriguez Y, Baltodano P, Tower A, Martinez C, Carrillo R. Management of symptomatic inadvertently placed endocardial leads in the left ventricle.Pacing Clin Electrophysiol. 2011;34:1192–200. [DOI] [PubMed]
Qin D, Filippaios A, Murphy J, Berg M, Lampert R, Schloss EJ, et al. Short- and Long-Term Risk of Lead Dislodgement Events: Real-World Experience From Product Surveillance Registry.Circ Arrhythm Electrophysiol. 2022;15:e011029. [DOI] [PubMed]
Kawata H, Patel J, McGarry T, Joshi R, Krummen D, Feld G, et al. Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation.Int J Cardiol. 2014;172:522–4. [DOI] [PubMed]
Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.Mayo Clin Proc. 1984;59:17–20. [DOI] [PubMed]
Miranda B, Fonseca AC, Ferro JM. Patent foramen ovale and stroke.J Neurol. 2018;265:1943–9. [DOI] [PubMed]
Sogade OO, Aben RN, Eyituoyo H, Arinze NC, Sogade FO. Feasibility study for echocardiography-guided lead insertion for permanent cardiac implantable electronic devices.Pacing Clin Electrophysiol. 2021;44:1365–70. [DOI] [PubMed] [PMC]
Issa ZF, Rumman SS, Mullin JC. Inadvertent transarterial insertion of atrial and ventricular defibrillator leads.J Interv Card Electrophysiol. 2009;24:63–6. [DOI] [PubMed]
Van Gelder BM, Bracke FA, Oto A, Yildirir A, Haas PC, Seger JJ, et al. Diagnosis and management of inadvertently placed pacing and ICD leads in the left ventricle: a multicenter experience and review of the literature.Pacing Clin Electrophysiol. 2000;23:877–83. [DOI] [PubMed]
Costelloe CM, Murphy WA Jr, Gladish GW, Rozner MA. Radiography of pacemakers and implantable cardioverter defibrillators.AJR Am J Roentgenol. 2012;199:1252–8. [DOI] [PubMed]
Miller JD, Nazarian S, Halperin HR. Implantable Electronic Cardiac Devices and Compatibility With Magnetic Resonance Imaging.J Am Coll Cardiol. 2016;68:1590–8. [DOI] [PubMed]
Spighi L, Notaristefano F, Piraccini S, Giuffrè G, Barengo A, D’Ammando M, et al. Inadvertent Lead Malposition in the Left Heart during Implantation of Cardiac Electric Devices: A Systematic Review.J Cardiovasc Dev Dis. 2022;9:362. [DOI] [PubMed] [PMC]
Schulze MR, Ostermaier R, Franke Y, Matschke K, Braun MU, Strasser RH. Images in cardiovascular medicine. Aortic endocarditis caused by inadvertent left ventricular pacemaker lead placement.Circulation. 2005;112:e361–3. [DOI] [PubMed]
Solano J, Admed D, Ahmed A, Abbas S, Ahmed A, Antony R. Navigating Misplaced Leads: A Case of Left Ventricle (LV) Lead Placement via a Patent Foramen Ovale (PFO) in a Dual-Chamber Permanent Pacemaker (PPM).Cureus. 2025;17:e82835. [DOI] [PubMed] [PMC]
Taieb JM, Barnay C, Linde C, Mortensen P, Menardis M. Left atrial far-field sensing by left ventricular leads: a potential hazard in cardiac resynchronisation therapy.Europace. 2005;7:611–6. [DOI] [PubMed]
Butzke da Motta H, Kouz R, Sturmer M, Hadjis A, Becker G, Cerantola M. Extraction of a misplaced left ventricular pacing lead with complete embolic cerebral protection and intracardiac echocardiography visualization.HeartRhythm Case Rep. 2024;10:326–9. [DOI] [PubMed] [PMC]
Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul CI, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017;14:e503–51. [DOI] [PubMed]
Kennergren C, Bjurman C, Wiklund R, Gäbel J. A single-centre experience of over one thousand lead extractions.Europace. 2009;11:612–7. [DOI] [PubMed] [PMC]
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al.; ESC Scientific Document Group. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.Eur Heart J. 2021;42:3427–520. [DOI] [PubMed]
Trohman RG, Sharma PS. Detecting and managing device leads inadvertently placed in the left ventricle.Cleve Clin J Med. 2018;85:69–75. [DOI] [PubMed]
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.Eur Heart J. 2021;42:373–498. [DOI] [PubMed]
Pellegrini P, Conte L, Angheben C, Pacchioni A. A right wire in the wrong place.Intern Emerg Med. 2024;19:577–9. [DOI] [PubMed]
Nisam S, Reddy S. The story of … a lead.Europace. 2015;17:677–88. [DOI] [PubMed]